| Eliza D'agostino, | |
|
129 King St, Northampton, MA 01060-3258 | |
| (413) 397-8986 | |
| Not Available |
| Full Name | Eliza D'agostino |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 129 King St, Northampton, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306267950 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Eliza D'agostino, 129 King St, Northampton, MA 01060-3258 Ph: (413) 397-8986 | Eliza D'agostino, 129 King St, Northampton, MA 01060-3258 Ph: (413) 397-8986 |
News Archive
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) to market preservative-free Heparin Lock Flush Solution, USP in two dosage strengths, 10 USP Units/1 mL and 100 USP Units/1 mL, and will soon launch these single dose vial presentations.
In a press release the U.S. Food and Drug Administration has said that the agency would focus on a new public health education campaign that would discourage the use of e-cigarettes and other electronic nicotine delivery systems (ENDS) by kids. The campaign is titled "The Real Cost".
Research has shown that poor oral health can have a negative impact on seniors' overall health and well-being, but for many, there are significant barriers to visiting a dentist, finds a new report in the American Journal of Health Behavior.
EKOS Corporation announced today that Dr. David W. Newell, Co–Executive Director, Swedish Neuroscience Institute (Seattle, WA) presented a SNI clinical study known as ‘SLEUTH' (Safety of Lysis with Ultrasound in the Treatment of Intracerebral (ICH) and Intraventricular Hemorrhage (IVH) at the American Heart Association International Stroke Conference (San Antonio, TX).
Comorbid attention-deficit hyperactivity disorder is common in patients with bipolar disorder (BD), and is associated with more mixed states, more severe psychopathology, and more impaired family functioning, Italian researchers report.
› Verified 1 days ago
Jeanne Griffin Tuthill, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 228 Pleasant St, Northampton, MA 01060 Phone: 413-588-5266 Fax: 413-584-8592 | |
Karen Laclair, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 216 N King St, Northampton, MA 01060 Phone: 413-585-1400 | |
Ms. Amy Bleiweiss X, SPEECH LANGUAGE PATH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 53 Clark Ave, Unit 2, Northampton, MA 01060 Phone: 413-582-1811 | |
Ms. Beverly Mara Blatt, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 243 King St, Suite 242, Northampton, MA 01060 Phone: 413-584-0265 Fax: 413-584-2031 | |
Renee Riley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 216 N King St, Northampton, MA 01060 Phone: 413-585-1400 | |
Danielle Baker, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 228 King St Ste 2, Northampton, MA 01060 Phone: 413-727-8552 | |
Ms. Lori Allison Fromowitz, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 27 Winter St Apt 2, Northampton, MA 01060 Phone: 206-383-3810 |